Frost & Sullivan's latest analysis, Growth Opportunities in Global Pharmaceutical Industry, 2026, finds that the pharmaceutical industry is entering a period of profound transformation as ...

Swiss pharmaceutical companies are warning that a proposal to cap the country's population at 10 million could restrict ...

Patients in every other wealthy country already get the medications they need at prices their governments negotiated on their ...

Companies see a commercial opportunity in creating new ways to administer drugs to patients – in space.

Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the ...

The global pharmaceutical industry has found itself at the heart of geopolitical and trade tensions. The Trump administration ...

We've seen 80% adoption in 12 months, in a federal agency with a reduced headcount. The private sector has fewer excuses than ...

Germany's pharmaceutical industry faces fundamental challenges, as the cancellation of planned investments by giants Eli ...

In Guzzardi’s view, it wasn’t a coincidence that the three no-shows accepted more campaign contributions from the drug industry than most other state lawmakers nationwide: Between $6,000 and $15,000 ...

Commerce Minister Piyush Goyal stated that India's $60 billion pharmaceutical industry will double in five years, driven by ...

ABU DHABI, 11th June May, 2026 (WAM) -- ADCAN Pharma, a leading UAE-based pharmaceutical manufacturer distinguished as the nation’s first producer of oncology and hormone products, has announced a ...